-
SB 431542: Reliable ALK5 Assay Design
2026-09-11
Learn how SB 431542 (SKU A8249) can improve interpretation of cell viability, proliferation, and cytotoxicity assays by linking TGF-β receptor inhibition to appropriate controls and orthogonal endpoints. This scenario-based guide covers formulation, dosing, selectivity, data interpretation, and practical vendor-selection criteria.
-
Ashwagandha Digestion Revealed by LC–MS/MS
2026-09-10
This 2026 study combines simulated gastrointestinal digestion, LC–MS/MS profiling, untargeted metabolomics, and molecular networking to determine how Withania somnifera constituents change before absorption. Its selective stability findings for withaferin A, withanolide A, withanoside IV, and extract-level withanolides show why botanical bioavailability studies must account for digestive transformation rather than relying only on liver metabolism or plasma binding.
-
Substance P: Designing Reliable NK-1 Assays
2026-09-10
Substance P is a tachykinin neuropeptide central to pain transmission, inflammation, and CNS signaling. This guide presents an interference-aware framework for selecting biological endpoints, handling B6620, and interpreting spectral data without confusing analytical signals with receptor biology.
-
PRV, TLR–NF-κB, and AIM2 Inflammasome Signaling
2026-09-09
The reference study defines how pseudorabies virus coordinates TLR2, TLR3, TLR4, TLR5, NF-κB, AIM2, and GSDMD to drive inflammatory cytokine production in macrophages and mice. Its main contribution is separating transcriptional priming from inflammasome-dependent cytokine maturation, providing a mechanistic framework for antiviral inflammation research.
-
MHY1485: mTOR Activator and Autophagy Tool
2026-09-09
MHY1485 is an mTOR activator that suppresses autophagic flux by limiting autophagosome–lysosome fusion in described cellular models. Its research applications include autophagy assay design, ovarian follicle development research, and mechanistic studies of mTOR-regulated cell survival.
-
GI 254023X: ADAM10 Inhibitor Workflows
2026-09-08
GI 254023X combines nanomolar ADAM10 inhibition with strong ADAM17 selectivity for dissecting sheddase-dependent signaling, endothelial barrier injury, and Jurkat-cell responses. This practical guide connects target engagement to functional assays, controls, and troubleshooting strategies that improve interpretation and reproducibility.
-
Rapamycin (Sirolimus): Reliable Assay Design
2026-09-08
A scenario-based guide to using Rapamycin (Sirolimus), SKU A8167, when viability and proliferation assays produce inconsistent results. It links mTOR biology with solvent control, dose selection, orthogonal endpoints, mitochondrial interpretation, and practical product-selection criteria.
-
Epacadostat: Turning IDO1 Biology into Translation
2026-09-07
Epacadostat (INCB024360) offers translational researchers a precise way to interrogate IDO1-driven immune suppression. By connecting biochemical potency with standardized whole-blood immunometabolism, T-cell function, and checkpoint-combination strategy, this article outlines a decision framework that extends beyond conventional product-page specifications.
-
HIPK4–RIMBP3 Phosphorylation in Spermiogenesis
2026-09-07
The reference study links HIPK4 mutations to nonobstructive azoospermia and identifies RIMBP3 as a phosphorylation-regulated manchette protein during sperm development. By combining human variant analysis, Hipk4-deficient testes, phosphoproteomics, and substrate validation, the work connects protein phosphorylation signaling with sperm head morphogenesis and male fertility.
-
Gap26 for 3D Osteocyte Calcium Signaling
2026-09-05
Gap26 adds a controlled connexin 43 perturbation to 3D osteocyte networks exposed to pulsatile flow, helping separate cell-autonomous calcium responses from signal propagation. This workflow connects mechanobiology with ATP release inhibition while providing practical controls for peptide preparation, dosing, imaging, and interpretation.
-
AI-10-49: Mapping CBFβ-SMMHC Dependence
2026-09-04
AI-10-49 is a selective CBFβ-SMMHC inhibitor for mechanistic acute myeloid leukemia research. This article presents an evidence-chain strategy that separates target engagement, chromatin recovery, transcriptional remodeling, and leukemia-cell survival.
-
Thermal-Protective Hydrogel for Curative Tumor Ablation
2026-09-04
The reference study presents an injectable MR@CaP@HA hydrogel that combines local thermal insulation with pH- and glutathione-responsive delivery of mitoxantrone and Resiquimod (R-848) during radiofrequency ablation. In preclinical models, this design protected adjacent tissue, promoted immunogenic cell death and innate immune activation, and achieved complete tumor eradication in a subset of treated animals.
-
Early Life Adversity, Oxytocin, and Innate Defense
2026-09-03
A 2026 Communications Biology study shows that social deprivation during postnatal days 10–20 weakens looming-evoked innate defensive behavior in mice through impaired oxytocin signaling in the superior colliculus. By combining behavioral testing, receptor knockdown, circuit analysis, and intranasal oxytocin rescue, the work connects early environmental adversity to a defined neural mechanism.
-
SC 79: Akt Activation for Reliable Cell Assays
2026-09-03
Learn how SC 79 (SKU B5663) can serve as a mechanistic Akt activator in neuronal survival, senescence, and cell-assay workflows. This scenario-based guide covers compatibility, stock preparation, interpretation of viability data, and practical vendor-selection criteria.
-
Silymarin Workflows for Oxidative Stress Research
2026-09-02
Silymarin, a chemically diverse milk thistle extract, supports aligned workflows spanning redox biology, hepatocellular carcinoma, metabolic regulation, and antiviral screening. This guide converts its solubility limits and flavonolignan composition into practical dosing, controls, assay choices, and troubleshooting steps.